HIF1A and hepatocellular carcinoma: Patients who expressed high levels of HIF-1α were associated with a worse outcome, with a pooled risk for overall survival (RR  = 1.508) that was similar to that obtained in a recently published study on hepatocellular carcinoma (HR  = 1.65) [24].